About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $170M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Xy Capital LTD Portfolio

Follow Xy Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xy Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xy Capital LTD with notifications on news.